Search
for
Sort by
Research 151–180 of 1000+
- The role of androgen therapy
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone–binding globulin and androgen receptor polymorphisms
- Antiandrogen therapy for androgenetic alopecia
- Endocrine disorders and hormonal therapy for adolescent acne
- Hormonal Therapy for Acne
- Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up
- Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk
- Clinical markers of hyperandrogenism and response to conventional antibiotic therapy in women with acne vulgaris
- Advances in Stem Cell-Based Therapy for Hair Loss.
- Re‐Innovation in Clinical Trial Designs Based on Precision Therapy
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- A combination therapy for androgenic alopecia based on quercetin and zinc/copper dual-doped mesoporous silica nanocomposite microneedle patch
- Exosomes as Emerging Therapeutics in Aesthetic and Regenerative Medicine: A Scoping Review
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Personalized character of transgender medicine as a barrier to development of evidence-based clinical practice guidelines on gender incongruence
- Differences in male and female pattern hair loss based on androgens, estrogen, iron, vitamin D, lipid metabolism, and genetic regulation
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- A multifunctional cholesterol-free liposomal platform based on protopanaxadiol for alopecia therapy
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Anti-androgenic therapy with finasteride in patients with chronic heart failure – a retrospective propensity score based analysis
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Unrevealing the Potential of Sansevieria trifasciata Prain Fraction for the Treatment of Androgenetic Alopecia by Inhibiting Androgen Receptors Based on LC-MS/MS Analysis, and In-Silico Studies